Guidance: The Northern Ireland MHRA Authorised Route (NIMAR)

Medicines Healthcare Products Regulatory Agency

September 29
15:01 2023


The above provides guidance for key stakeholders in the medicines supply chain to facilitate their use of the NIMAR regulatory route for the continued supply of GB licensed medicines to NI.

Published 24 May 2022
Last updated 29 September 2023 +show all updates
  1. Information added about transitional arrangements for licences associated with the implementation of the Windsor Framework and links to relevant guidance.

  2. Added section on 'Advertising and promotions' to NIMAR guidance.

  3. First published.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: